Home
Resources
Follow portfolio news
...

ASG Eye Hospitals continues to expand in India with new initiatives

Published on
11/10/2024
Amended on
2/8/2026
0
minute(s)
Odyssey 2021
ASG Eye Hospitals
ASG Eye Hospital, one of India’s leading eye care providers and a participant in the Vintage Altaroc Odyssey , continues to expand its presence with major developments at two of its centers, in Noida and Calicut. Founded in 2005 by Dr. Arun Singhvi and Dr. Shilpi Gang, alumni of AIIMS in New Delhi, the company’s mission is to provide high-quality eye care to everyone, regardless of their financial status or level of education.
By
Damien Hélène
Damien Hélène
ASG Eye Hospitals continues to expand in India with new initiatives
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

ASG Eye Hospitals is expanding its hospital network in India with two new strategic openings

The ASG Eye Hospitals Group, one of India's leading eye care providers, has taken another major step forward in its national expansion plan. With the support of its major shareholders as part of a sector consolidation strategy, the group has just opened two state-of-the-art facilities in Noida and Calicut.

This two-part initiative expands ASG's network to more than 160 centers across the country, strengthening a healthcare model that now treats more than 4.5 million patients each year. This expansion is supported by a total investment of $150 million allocated to the modernization of medical facilities and the acquisition of regional clinics.

A new facility in Noida for 24/7 care

A few weeks ago, ASG Eye Hospitals opened a new facility in Noida. This facility, which operates around the clock, offers specialized care for all complex eye conditions. Located at V-21A, Atta Market, Sector 27, it provides treatments for conditions such as cataracts, LASIK, glaucoma, retinal diseases, neuro-ophthalmology, and many others. The goal is to ensure that Noida residents have easy access to state-of-the-art eye care, even in emergencies or outside regular hours, including on weekends. The medical team at this new facility is composed of renowned doctors.

The Noida facility stands out from the local competition by having earned NABH (National Accreditation Board for Hospitals & Healthcare Providers) certification, the highest mark of quality in healthcare in India. In terms of technology, the center features state-of-the-art refractive surgery platforms, including the cutting-edge Contoura Vision technology, which enables personalized corneal mapping for laser corrections with microscopic precision, surpassing standard LASIK treatments.

Expansion of the vitreous surgery department in Calicut

Meanwhile, ASG Vasan Eye Hospital in Calicut recently announced an expansion of its vitrectomy surgery department, an advanced treatment for retinal disorders. Thanks to the addition of continuously available retinal surgeons, patients can now access specialized care at any time.

Vitrectomy is a vital surgical procedure that restores vision in people with complex retinal disorders, thereby improving their quality of life. By bringing in surgeons trained at the country’s most prestigious ophthalmic institutes, the Calicut unit is able to treat cases of advanced diabetic retinopathy or retinal detachment within critical timeframes—often within two hours of admission.

An ongoing commitment to accessible care

ASG Eye Hospitals stands out for its commitment to providing high-tech care at affordable prices. With locations in key cities such as Calicut, Thrissur, Kochi, Kottayam, and Trivandrum, the hospital group is accessible to a wide range of people and accepts all insurance plans, including the ECHS program for veterans.

Patient feedback and testimonials regularly highlight this affordability combined with emergency care. Many families emphasize the relief they felt at being able to undergo phacoemulsification (sutureless) cataract surgery on a holiday, at no additional cost and with full coverage through their third-party payment plan.

With a modern infrastructure and services available 24/7, ASG continues to establish itself as a major player in India's eye care sector, transforming a fragmented healthcare market into a standardized, high-performing national network.

Advertising communication. Please refer to the FIA prospectus and key investor information documents before making any final investment decision. Private equity involves a risk of capital loss and a liquidity risk. Past performance is no guarantee of future results.  

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
Welcome to Altaroc
In accordance with applicable regulations, we ask that you complete your profile. This step is required to access the content and services offered on our websites.
Please fill out your profile to access the site
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Select your language and investor profile to continue
Select your investor profile to continue
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.